secwatch / observer
8-K filed September 29, 2023, 7:59 PM ET ticker SNX CIK 0001177394
leadership confidence high sentiment neutral materiality 0.30

TD SYNNEX appoints Kathleen Crusco and Claude Pumilia to board, expanding from 11 to 13 members

TD SYNNEX CORP

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Claude Pumilia

Director
SNX · TD SYNNEX CORP
Effective
2023-09-28
Filed
September 29, 2023, 7:59 PM ET
On September 28, 2023, the Board of Directors of TD SYNNEX Corporation (“TD SYNNEX”) appointed Kathleen Crusco and Claude Pumilia as members of the TD SYNNEX Board of Directors
Appointed

Kathleen Crusco

Director
SNX · TD SYNNEX CORP
Effective
2023-09-28
Filed
September 29, 2023, 7:59 PM ET
On September 28, 2023, the Board of Directors of TD SYNNEX Corporation (“TD SYNNEX”) appointed Kathleen Crusco and Claude Pumilia as members of the TD SYNNEX Board of Directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Claude Pumilia was appointed as Director at TD SYNNEX CORP.

Action
appointed
Role
Director
Exact text from the filing
On September 28, 2023, the Board of Directors of TD SYNNEX Corporation (“TD SYNNEX”) appointed Kathleen Crusco and Claude Pumilia as members of the TD SYNNEX Board of Directors
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen Crusco was appointed as Director at TD SYNNEX CORP.

Action
appointed
Role
Director
Exact text from the filing
On September 28, 2023, the Board of Directors of TD SYNNEX Corporation (“TD SYNNEX”) appointed Kathleen Crusco and Claude Pumilia as members of the TD SYNNEX Board of Directors
View on SEC.gov

TD SYNNEX CORP filing history →

Source: SEC EDGAR
accession 0001193125-23-246482
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.